Mass General Imaging - Worcester now introduces 3D mammography technology that promises to improve breast cancer detection.
Mass General Imaging brings 3D mammography to Worcester
Grove Street facility becomes second Massachusetts location providing new technology that promises better breast cancer detection and fewer false positives.
WORCESTER, Mass., — Mass General Imaging - Worcester now introduces 3D mammography at its 385 Grove St. location, providing women with convenient, local access to a new technology that promises to improve breast cancer detection while also reducing callbacks and the anxiety they cause.
3D mammography, also known as tomosynthesis, improves the radiologists' ability to screen for and detect potential breast cancers by helping to pinpoint the size, shape, and location of abnormalities. This helps the radiologist distinguish harmless structures from real tumors, leading to fewer repeat examinations.
"Tomosynthesis represents a huge step forward for mammography, capitalizing on its strengths and addressing its flaws.” said Elizabeth Rafferty, MD, director of Breast Imaging at Mass General. “By allowing us to look between and around the normal structures of the breast we are finding cancers that are simply not visible on standard digital mammograms. This technology is truly amazing, and it is our patients who will benefit."
Mass General Imaging's Breast Imaging Division, under Rafferty’s leadership, was instrumental in the development and clinical trials of tomosynthesis. The new technology received FDA approval in February, and Mass General Imaging performed the nation's first tomosynthesis exam in Boston in March.
Conventional mammography images the entire breast in one exposure, resulting in a 2D picture in which features can be hidden by overlapping tissue. 3D mammography takes images from multiple angles and uses computer processing to build these "slices" into a 3D image that a radiologist can manipulate to get a clearer view. "Like flipping through the pages of a book, the radiologist is able to look at one page at a time instead of seeing the whole breast reduced to a single snapshot, as is the case with standard mammography," Rafferty said.
Tomosynthesis is complementary to standard mammography, which remains the "gold standard" for breast cancer detection. Experts expect tomosynthesis to eventually become the new gold standard, but for now, tomosynthesis is performed at the same time as a normal mammogram, on the same scanner. There is essentially no noticeable difference in the experience or time for the patient. Breast tomosynthesis will be available to all patients receiving screening and diagnostic mammograms.
To learn more about breast tomosynthesis please visit www.3Dmammo.org. To schedule an exam or for more information, please call Mass General Imaging - Worcester at (508) 849-5003.
Celebrating the 200th anniversary of its founding in 1811, Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $700 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, reproductive biology, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.
Media Contacts: Mike Morrison: 617-724-6425; email@example.com